TP Therapeutics Funding & Investors
San Diego, CA
Turning Point Therapeutics, Inc. operates as a biopharmaceutical company. The Company designs and develops novel small molecule to treat cancer related diseases. Turning Point Therapeutics serves medical sector in the United States.
tptherapeutics.comTotal Amount Raised: $1,180,709,760
TP Therapeutics Funding Rounds
Post Ipo Equity
$460,000,000
Post Ipo Equity
$373,800,000
Post Ipo Equity
$202,500,000
IPO
Unknown
Private Equity
$80,000,000
Private Equity Investors
Foresite CapitalvenBio PartnersHBM Healthcare InvestmentsSr OneNextech InvestCormorant Asset ManagementLilly Asia VenturesKenson VenturesOrbiMed AdvisorsSeries C
$45,000,000
Series C Investors
Lilly Asia VenturesOrbiMed AdvisorsSr OneCormorant Asset ManagementSV Tech VenturesSeries B
$17,979,732
Series Unknown
$1,429,999
Funding info provided by Diffbot.